Æterna Zentaris to Present at BioFinance in Toronto on April 7
March 31 2010 - 7:30AM
PR Newswire (US)
QUÉBEC CITY, March 31
/PRNewswire-FirstCall/ - Æterna Zentaris Inc. (NASDAQ: AEZS, TSX:
AEZ), (the "Company") a late-stage drug development company
specialized in oncology and endocrinology, today announced that its
Senior Vice President and Chief Medical Officer, Paul Blake, MD, will present a corporate
overview at BioFinance on Wednesday, April
7, 2010, at 10:00 am (eastern
time), in the Trinity IV room, of the Toronto Marriott Eaton
Centre, in Toronto, Canada.
About Æterna Zentaris Inc.
Æterna Zentaris Inc. is a late-stage drug development company
specialized in oncology and endocrinology. News releases and
additional information are available at www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.
Copyright h 31 PR Newswire
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jul 2023 to Jul 2024